Skip to content

Clinical observation for shock wave combined with platelet-rich plasma femoral head perfusion in the treatment of C1 femoral head necrosis

Clinical observation for shock wave combined with platelet-rich plasma femoral head perfusion in the treatment of C1 femoral head necrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018973
Enrollment
Unknown
Registered
2018-10-19
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis of the Femeral Head

Interventions

Group 1:Shock wave combined with PRP perfusion
Group 2:Shock wave combined with borehole decompression
Group 3:Shock wave therapy

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-55 years old, male or female, non-traumatic femoral head necrosis; (2) X-ray of the hip joint is showing C1 type femoral head necrosis; (3) Patients with ARCO stage of ONFH who are stage II with significant pain and patients with stage IIIA with pain or limited mobility; (4) The affected femoral head did not collapse or collapsed less than 4mm, the joint space was not significantly narrow, and the head-to-head matching relationship was good; (5) The patient agrees to participate in the trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with other diseases that affect the progression of ONFH (such as heart disease, liver and kidney system major diseases, nephrotic syndrome, systemic lupus erythematosus, etc. still need to take hormones) and are active; (2) The patient cannot withstand shock wave treatment due to tolerance problems.

Design outcomes

Primary

MeasureTime frame
Pain score;Joint mobility;Harris score;SF-12 score;Collapse rate;Lateral Wall Index, LWI;Height change of collapse;Head lice index;Medial space of the femoral head;Bone marrow edema classification;Femoral head cartilage thickness;

Countries

China

Contacts

Public ContactChi Zhou

Guangzhou University of Chinese Medicine

642899538@qq.com+86 15914305891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026